Impact Factor
3.06
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.40
228 total citations
h5-index
16
h5 depth signal
Cited share
70.2%
73 of 104
Total citations
228
Citation footprint
Metric signal
2.67
External metric anchor
Self-citation
5.3%
12 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
132
United Kingdom
95
India
92
Germany
78
Iran
74
Citing Fields of Research
Virology
177
Pharmacology & Toxicology
90
Viral Identification & Phylogenetics
86
Immunology
82
Clinical Laboratory Science
67
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,321
Articles tracked across the journal lifetime
Indexed publication set
104
73 cited publications
Last 12 months
31
2.6 publications/month
Open access share
25.8%
8 OA publications in the last year
Leading citing country
United States
132 citing publications
Leading citing field
Virology
177 citing publications
Latest tracked publication
10 October 2026
10 recent records available
Coverage & Indexing History
v18n1, Jan. 1990-
v18n1, Jan. 1990-
Active Coverage
Research Focus & Classification
Indexed Subjects
Virology
Pharmacology & Toxicology
Viral Identification & Phylogenetics
Clinical Laboratory Science
Immunology
Bacteriology
Issuing & Sponsoring Bodies
Contributor
International Association of Biological Standardization
Broad Categories
Allergy and Immunology
Technology
Virology
Separation Techniques
Viral Identification & Phylogenetics
Medical Ethics
Immunotherapy
MeSH Descriptors
Biological Products
Biological Products
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.biologicals.2026.101918
Open DOI
Sterility testing in the era of decentralised cell therapy: Challenges, innovations, and future directions
02
DOI 10.1016/j.biologicals.2026.101917
Open DOI
Optimization of viral reference databases for NGS-based viral safety testing reduces background signals while preserving detection sensitivity
03
DOI 10.1016/j.biologicals.2026.101914
Open DOI
Globally harmonized specifications: Implementing a patient-centric, enhanced control strategy – a meeting report
04
05
DOI 10.1016/j.biologicals.2026.101915
Open DOI
Optimization of clesrovimab cell-based assay with improved precision and throughput
06
DOI 10.1016/s1045-1056(26)00036-9
Open DOI
Aims and Scope/Editorial Board/Publishing Details
07
08
DOI 10.1016/j.biologicals.2026.101903
Open DOI
Report of the international conference on animal testing replacement for vaccines: A one health view on global outlook and future strategy
09
10
DOI 10.1016/j.biologicals.2026.101906
Open DOI
Development of a novel competitive ELISA method for Typhoid Vi Polysaccharide Quantitation
Bibliographical & Catalog Notes
Title from cover.
Also i ssued online.
Articles chiefly in English with some in French; French articles have summaries in both languages.
Vol. 1990, no. 18, 3 (JUL 1990)19901101 Notice published Printed on acid-free paper